(Opioid Crisis 2.0 in the making?)
The cannabis use disorder (CUD) treatment market is on the brink of rapid expansion, reflecting a global trend towards recognising the health implications linked with cannabis dependency. Accelerated by increasing cannabis consumption, legislative movements, and a heightened awareness of usage-related risks, the market is forecast to grow from a valuation of USD 1.7 billion in 2025 to USD 2.7 billion by 2035, with a CAGR of 4.7% during the period.
This surge underscores the growing need for effective treatment interventions in response to rising dependency cases. Below, we’ll explore the driving forces behind this expansion and examine how different regions and innovations are shaping the market’s trajectory.
Impact of Rising Cannabis Use Cases: The increasing legalisation of cannabis across various markets, such as North America, Europe, and parts of Asia, has brought a profound shift in consumption rates. While cannabis is often lauded for its recreational and medicinal benefits, the uptick in usage has contributed to a parallel rise in dependency cases and cannabis-related health concerns, including cognitive impairment and mental health disorders like anxiety and depression.
Healthcare systems globally are ramping up investments in interventions to address these concerns. Scientific research highlights that long-term cannabis use can lead to dependency and withdrawal symptoms, which have sparked efforts to develop both behavioural and pharmacological treatments.
(For complete Article WRD News)
